Skip to content
Clinical Trials for Alzheimer's Disease

Georgia

Alzheimer's disease clinical trials in Georgia

27 Alzheimer's disease studies are recruiting participants at sites in 10 cities across Georgia as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Georgia city with a recruiting study

Atlanta (13), Decatur (6), Columbus (4), Gainesville (4), Augusta (2), Savannah (2), Gainsville (1), Snellville (1), Valdosta (1), Woodstock (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Georgia

Basic details from each study's public record (the 12 most recently updated of 27). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Atlanta · Columbus · Decatur · and 1 more U.S. location
    Registry record
    NCT07177352 · updated
  2. Adaptango Performance PRocess for Older Adults Community reHabilitation

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Emory University
    Recruiting in
    Atlanta
    Registry record
    NCT07824128 · updated
  3. Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Recruiting in
    Atlanta
    Registry record
    NCT05980949 · updated
  4. A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    MapLight Therapeutics
    Recruiting in
    Augusta · Snellville
    Registry record
    NCT06887192 · updated
  5. A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

    • Phase 3
    • Ages 55 to 80
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Recruiting in
    Columbus
    Registry record
    NCT07717411 · updated
  6. ACP-204 in Adults With Alzheimer's Disease Psychosis

    • Phase 2/3
    • Ages 55 to 95
    • All sexes
    Sponsor
    ACADIA Pharmaceuticals Inc.
    Recruiting in
    Atlanta
    Registry record
    NCT06159673 · updated
  7. Flutemetamol F 18 Injection Formulation Comparison

    • Phase 2
    • Ages 50 to 110
    • All sexes
    Sponsor
    GE Healthcare
    Recruiting in
    Gainesville
    Registry record
    NCT07873463 · updated
  8. A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

    • Phase 2
    • Ages 55 and older
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Recruiting in
    Savannah
    Registry record
    NCT06540833 · updated
  9. A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Recruiting in
    Atlanta
    Registry record
    NCT07011745 · updated
  10. A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

    • Phase 1
    • Ages 50 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Decatur
    Registry record
    NCT06297590 · updated
  11. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    • Phase 3
    • Ages 55 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Recruiting in
    Gainesville · Woodstock
    Registry record
    NCT07602582 · updated
  12. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Recruiting in
    Atlanta
    Registry record
    NCT06585787 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Georgia on ClinicalTrials.gov.

Ask about studies in Georgia

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call